ENVVENO MEDICAL CORP (NVNO) Stock Cash Flow
NASDAQ:NVNO - Nasdaq - US29415J1060 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -23.07M | -21.82M | -23.52M | -24.67M | -16.53M | |||
| Depreciation Amortization | 500.00K | 528.00K | 546.00K | 210.00K | 150.00K | |||
| Change In Working Capital | 954.00K | 290.00K | -616.00K | -420.00K | -1.46M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 4.50M | 4.16M | 4.73M | 9.26M | 5.99M | |||
| OPERATING CASH FLOW | -17.11M | -16.84M | -18.86M | -15.62M | -11.85M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -37.00K | -33.00K | -120.00K | -370.00K | |||
| Other Investing Activity | 3.20M | 1.37M | -7.83M | -34.44M | N/A | |||
| INVESTING CASH FLOW | 3.19M | 1.33M | -7.87M | -34.55M | -370.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 13.64M | N/A | N/A | 57.61M | |||
| Other Financing Activity | N/A | N/A | 25.79M | 0.00 | N/A | |||
| FINANCING CASH FLOW | N/A | 13.64M | 25.79M | 0.00 | 57.61M | |||
| CHANGE IN CASH | -336.00K | -1.87M | -935.00K | -50.17M | 45.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.11M | -16.84M | -18.86M | -15.62M | -11.85M | |||
| Capital Expenditure | N/A | -37.00K | -33.00K | -120.00K | -370.00K | |||
| FREE CASH FLOW | -17.13M | -16.88M | -18.89M | -15.74M | -12.22M | |||
All data in USD